UnitedHealth Group (NYSE:UNH) Trading 1.5% Higher - Time to Buy?

Key Points

• UnitedHealth shares rose about 1.5% amid analyst support (notably a Raymond James upgrade) and increased institutional interest, leaving a MarketBeat consensus of Moderate Buy and an average price target of $363.38.
• The upcoming Q1 report on April 21 is the key near‑term catalyst: the company faces downside risk after a ~22% six‑month pullback and softer guidance, but its Medicare Advantage and value‑based care franchises could drive upside if margins recover.

UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) shares traded up 1.5% on Monday . The company traded as high as $283.30 and last traded at $281.4640. 5,890,940 shares traded hands during trading, a decline of 39% from the average session volume of 9,624,309 shares. The stock had previously closed at $277.26.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Raymond James upgraded UNH ahead of the Q1 print, signaling increased analyst conviction that management can show stabilization or progress next week. Raymond James Boosts UnitedHealth (UNH) Rating Before Q1 Results
• Positive Sentiment: High-profile investor interest: coverage noting billionaire Ken Griffin’s sizable exposure to UNH reinforces institutional confidence and may support demand for the shares. Is UnitedHealth Group (UNH) The Best Healthcare Stock to Buy According to Billionaire Ken Griffin?
• Positive Sentiment: Several bullish takes argue UNH's pullback has priced in risks and that its Medicare Advantage franchise and value-based care model give upside if margins recover. These narratives support the recovery trade into earnings. UnitedHealth: Why It's Still Not Too Late To Buy The Turnaround
• Neutral Sentiment: Q1 earnings preview pieces highlight analyst support but note weak guidance is already a risk — the upcoming report is the key near-term catalyst that could swing sentiment either way. UnitedHealth Q1 Earnings Preview: What To Expect From Upcoming Report
• Neutral Sentiment: Outlets emphasize April 21 as a make-or-break quarter — investors are positioning for either validation of management’s recovery or renewed questions if results disappoint. Is April 21 When UnitedHealth Group Finally Sheds Its Problem Past?
• Neutral Sentiment: Macro/sector drivers: a report on expected new Medicare payment rates matters for UNH because ~35M beneficiaries are in Medicare Advantage — payment changes could materially affect revenue/margins but direction depends on the final rate. New Medicare Payment Rate Expected. Why It’s a Big Deal for Healthcare Stocks.
• Neutral Sentiment: Broad market strength (Dow higher) is providing a mild tailwind to stocks including UNH today. Stock Market Today: Dow Up As Oil Pops; Bank Play Eyes Entry After This 'Trump Accounts' Move (Live Coverage)
• Negative Sentiment: Near-term headwinds remain: commentary highlighting a ~22% decline over six months, softer quarterly results and below-trend guidance is keeping downside risk elevated if Q1 fails to show clear recovery. 2 Reasons to Watch UNH and 1 to Stay Cautious

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on UNH shares. Raymond James Financial raised shares of UnitedHealth Group from a "market perform" rating to an "outperform" rating and set a $330.00 price objective for the company in a research report on Wednesday, April 1st. Barclays lowered their price target on UnitedHealth Group from $391.00 to $327.00 and set an "overweight" rating on the stock in a research report on Friday, January 30th. Mizuho reduced their target price on UnitedHealth Group from $430.00 to $350.00 and set an "outperform" rating for the company in a research note on Thursday, February 5th. Leerink Partners decreased their price target on shares of UnitedHealth Group from $410.00 to $345.00 and set an "outperform" rating on the stock in a research note on Wednesday, January 28th. Finally, Piper Sandler restated an "overweight" rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $363.38.

UnitedHealth Group Stock Up 1.5%

The firm's 50 day simple moving average is $283.03 and its two-hundred day simple moving average is $319.62. The firm has a market cap of $255.48 billion, a price-to-earnings ratio of 21.34, a PEG ratio of 1.28 and a beta of 0.40. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.72.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $2.09 by $0.02. The company had revenue of $113.73 billion for the quarter, compared to analysts' expectations of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business's revenue for the quarter was up 12.3% on a year-over-year basis. During the same period last year, the firm earned $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were given a $2.21 dividend. The ex-dividend date was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.1%. UnitedHealth Group's dividend payout ratio (DPR) is presently 67.02%.

Hedge Funds Weigh In On UnitedHealth Group

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Norges Bank acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $4,376,167,000. Capital Research Global Investors raised its holdings in shares of UnitedHealth Group by 126.9% during the 3rd quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate's stock worth $4,503,419,000 after buying an additional 7,293,009 shares in the last quarter. Berkshire Hathaway Inc acquired a new stake in UnitedHealth Group in the second quarter valued at about $1,572,193,000. Capital World Investors raised its stake in UnitedHealth Group by 18.8% during the third quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate's stock worth $7,516,107,000 after acquiring an additional 3,439,182 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. lifted its holdings in shares of UnitedHealth Group by 141.9% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 4,109,029 shares of the healthcare conglomerate's stock worth $1,356,432,000 after acquiring an additional 2,410,128 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.